Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study. (Q38761739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

1 reference

Haritz Jimenez-Urbieta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Rosalía Dacosta-Aguayo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Irene Navalpotro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

Maria Cruz Rodriguez Oroz

21 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Manuel Delgado-Alvarado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Belén Gago

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Ana Gorostidi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Javier Ruiz-Martínez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Alberto Bergareche

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

José F Martí-Massó

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Pablo Martínez-Lage

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Andrea Izagirre

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

26 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

1066-1073

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 March 2020

cites work

1 reference

Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease

21 January 2018

1 reference

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

MDS research criteria for prodromal Parkinson's disease

21 January 2018

1 reference

Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis

21 January 2018

1 reference

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

21 January 2018

1 reference

The neurobiological basis of cognitive impairment in Parkinson's disease

21 January 2018

1 reference

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

21 January 2018

1 reference

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

21 January 2018

1 reference

Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.

21 January 2018

1 reference

Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism

21 January 2018

1 reference

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

21 January 2018

1 reference

The Parkinson Progression Marker Initiative (PPMI).

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process

21 January 2018

1 reference

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

21 January 2018

1 reference

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

21 January 2018

1 reference

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

21 January 2018

1 reference

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

21 January 2018

1 reference

Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease

21 January 2018

1 reference

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

21 January 2018

1 reference

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

21 January 2018

1 reference

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

21 January 2018

1 reference

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia

21 January 2018

1 reference

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

21 January 2018

1 reference

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism

21 January 2018

1 reference

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum

21 January 2018

1 reference

Correlation between serum RANTES levels and the severity of Parkinson's disease

21 January 2018

1 reference

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

21 January 2018

1 reference

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

21 January 2018

1 reference

Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies

21 January 2018

1 reference

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

The roles of TNF in brain dysfunction and disease

21 January 2018

1 reference

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

21 January 2018

1 reference

Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study

21 January 2018

1 reference

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

21 January 2018

1 reference

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

21 January 2018

1 reference

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.27001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548309%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference